Notch signaling regulates myogenic regenerative capacity of murine and human mesoangioblasts

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Quattrocelli, M ^a   Costamagna, D ^a   Giacomazzi, G ^a   Camps, J ^a   Sampaolesi, M ^a,b  

^a Translational Cardiomyology Lab Stem Cell Institute Leuven Department of Development and Regeneration ^*  (Belgium)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; DELTA LIKE LIGAND 1; DNA; DOXYCYCLINE; LIGAND; MEMBRANE PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; DLK1 PROTEIN, HUMAN; DLK1 PROTEIN, MOUSE; NOTCH1 PROTEIN, HUMAN; NOTCH1 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GAIT; HEMANGIOBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESANGIUM CELL; MESOANGIOBLAST; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NEWBORN; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; MYOBLAST; STEM CELL;

CANIS FAMILIARIS; MURINAE; MUS; MUS MUSCULUS;

ANIMALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEF2 TRANSCRIPTION FACTORS; MEMBRANE PROTEINS; MICE; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84928017925     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.401     Document Type: Article

References (29)

1. Kopan R, Ilagan MXG. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216-233.
2. Dutta D, Shaw S, Maqbool T, Pandya H, Vijayraghavan K. Drosophila Heartless acts with Heartbroken/Dof in muscle founder differentiation. PLoS Biol 2005; 3: e337.
3. Conboy IM, Rando TA. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 2002; 3: 397-409.
4. Mourikis P, Gopalakrishnan S, Sambasivan R, Tajbakhsh S. Cell-autonomous Notch activity maintains the temporal specification potential of skeletal muscle stem cells. Development 2012; 139: 4536-4548.
5. Rios AC, Serralbo O, Salgado D, Marcelle C. Neural crest regulates myogenesis through the transient activation of NOTCH. Nature 2011; 473: 532-535.
6. Schuster-Gossler K, Cordes R, Gossler A. Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proc Natl Acad Sci USA 2007; 104: 537-542.
7. Parker MH, Loretz C, Tyler AE, Duddy WJ, Hall JK, Olwin BB et al. Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells 2012; 30: 2212-2220.
8. DezawaM, Ishikawa H, Itokazu Y, Yoshihara T, HoshinoM, Takeda S et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005; 309: 314-317.
9. Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, Pellegrino MA et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003; 301: 487-492.
10. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007; 9: 255-267.
11. Cappellari O, Benedetti S, Innocenzi A, Tedesco FS, Moreno-Fortuny A, Ugarte G et al. Dll4 and PDGF-BB convert committed skeletal myoblasts to pericytes without erasing their myogenic memory. Dev Cell 2013; 24: 586-599.
12. Quattrocelli M, Palazzolo G, Floris G, Schöffski P, Anastasia L, Orlacchio A et al. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs. J Pathol 2011; 223: 593-603.
13. Roobrouck VD, Clavel C, Jacobs SA, Ulloa-Montoya F, Crippa S, Sohni A et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 2011; 29: 871-882.
14. Quattrocelli M, Palazzolo G, Perini I, Crippa S, Cassano M, Sampaolesi M. Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles. Methods Mol Biol 2012; 798: 65-76.
15. Crippa S, Cassano M, Messina G, Galli D, Galvez BG, Curk T et al. miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol 2011; 193:1197-1212.
16. Quattrocelli M, Crippa S, Montecchiani C, Camps J, Cornaglia AI, Boldrin L et al. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J Am Heart Assoc 2013; 2: e000284.
17. Shen H, McElhinny AS, Cao Y, Gao P, Liu J, Bronson R et al. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev 2006; 20: 675-688.
18. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-369.
19. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 1998; 103: 335-342.
20. Wen Y, Bi P, Liu W, Asakura A, Keller C, Kuang S. Constitutive Notch activation upregulates Pax7 and promotes the self-renewal of skeletal muscle satellite cells. Mol Cell Biol 2012; 32:2300-2311.
21. Katz MG, Fargnoli AS, Williams RD, Bridges CR. Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther 2013; 24: 914-927.
22. Bröhl D, Vasyutina E, Czajkowski MT, Griger J, Rassek C, Rahn H-P et al. Colonization of the satellite cell niche by skeletal muscle progenitor cells depends on Notch signals. Dev Cell 2012; 23: 469-481.
23. Brack AS, Conboy IM, Conboy MJ, Shen J, Rando TA. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2008; 2: 50-59.
24. Gargioli C, Coletta M, De Grandis F, Cannata SM, Cossu G. PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat Med 2008; 14: 973-978.
25. Woronicz JD, Lina A, Calnan BJ, Szychowski S, Cheng L, Winoto A. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol Cell Biol 1995; 15: 6364-6376.
26. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 1998; 142: 1461-1471.
27. Hampton TG, Kale A, Amende I, Tang W, McCue S, Bhagavan HN et al. Gait disturbances in dystrophic hamsters. J Biomed Biotechnol 2011; 2011: 235354.
28. Consalvi S, Mozzetta C, Bettica P, Germani M, Fiorentini F, Del Bene F et al. Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat. Mol Med 2013; 19: 79-87.
29. Brooker R, Hozumi K, Lewis J. Notch ligands with contrasting functions: Jagged1 and Delta1 in the mouse inner ear. Development 2006; 133: 1277-1286.